364P Elacestrant in combination with abemaciclib in patients (pts) with brain metastasis (mets) from estrogen receptor-positive (ER+), HER2-negative (HER2-) breast cancer: Preliminary data from ELECTRA, an open-label, multicenter, phase Ib/II study
Ciruelos, E.M., Hamilton, E.P., Kim, S-B., Im, Y-H., Solis, E. Segui, Saenz, J.Á. García, Di Sanzo, A., Lizarbe, M. Domínguez, Wasserman, T., Theall, K.P., Ibrahim, N.K.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
437TiP An open-label, multicenter, phase II study to evaluate the safety and efficacy of BB-1701, a novel antibody drug conjugate (ADC) targeting HER2, in previously treated patients (pts) with HER2+ or HER2-low unresectable or metastatic (M) breast cancer (BC)
George, M., Frenel, J-S., Cortés, J., Schmidt, M., Saenz, J.Á. García, Blau, S., Abdulla, N.E., Nishimura, M., Sakai, H., Babu, S., McAndrew, N.P., Ali, A., Pavic, M., Jhaveri, K., Jones, J.M., Rugo, H.S., Mody, K., Smith, A.D., Yamashita, T.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
202P Abemaciclib in HR+/Her2- metastatic breast cancer patients after previous progression on palbociclib or ribociclib: Clinical experience in a tertiary hospital in Madrid, Spain
De Luna Aguilar, A., Moreno Anton, F., Benitez Fuentes, J.D., Ortega Anselmi, J., Olalla Inoa, J., Flores Navarro, P., García Saenz, J.Á.
Published in Annals of oncology (01.05.2022)
Published in Annals of oncology (01.05.2022)
Get full text
Journal Article
241P Overall survival and updated invasive disease free survival results from the Penelope-B trial investigating palbociclib vs placebo for patients with high-risk HR+/HER2- breast cancer and residual disease after NACT
Loibl, S., Jimenez, M. Martin, Bonnefoi, H., Untch, M., Kim, S-B., Bear, H.D., McCarthy, N.J., Gelmon, K.A., Saenz, J.Á. García, Kelly, C.M., Reimer, T., Zhang, Z., Toi, M., Rugo, H.S., Gnant, M.I., Makris, A., Debiasi, M., Hirmas, N., Nekljudova, V., Marmé, F.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
414P The complex relationship between circulating tumor cells (CTCs) and brain metastases (BMs) in metastatic breast cancer (mBC): A retrospective pooled analysis
Pastò, B., Pierga, J-Y., Fehm, T.N., Saenz, J.Á. García, Caldas, C., Gazzaniga, P., Fernandez de Lascoiti, A., De Mattos-Arruda, L., Ignatiadis, M., Generali, D., Riethdorf, S., Solomayer, E-F., Reduzzi, C., Giuliano, M., Puglisi, F., Janni, W., Gerratana, L., Pantel, K., Bidard, F.C., Cristofanilli, M.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
261P Subtyping of residual disease (RD) following neoadjuvant chemotherapy (NACT) for triple negative breast cancer (TNBC): Evolution and prognostic impact
Diaz-Guardamino, I. Echavarria, Lopez-Tarruella Cobo, S., Del Monte-Millan, M., Alvarez, E., Gilarranz, Y. Jerez, Anton, F. Moreno, Saenz, J.Á. García, Massarrah, T., Ocaña, I., Cebollero, M., Garcia, A.I. Ballesteros, Sarmiento, U. Bohn, Gomez, H., Rivera, H. Fuentes, Lopez, B. Herrero, Polo, C., Bueno, O., Rahimi, P., Muiño, C. Bueno, Jimenez, M. Martin
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
258P Correlation between pathological complete response (pCR) following neoadjuvant docetaxel, carboplatin and trastuzumab (TCH) with or without pertuzumab (TCHP) and PAM50 subtypes in HER2(+) early breast cancer (eBC)
Muiño, C. Bueno, Diaz-Guardamino, I. Echavarria, Alvarez, E., Gilarranz, Y. Jerez, Lopez, B. Herrero, Del Monte, M., Massarrah, T., Cebollero, M., Nevado, M., Barrio, P.D.L.M. de la Morena, Ayala de la Pena, F., Saenz, J.Á. García, Anton, F. Moreno, Rodriguez, A., Verduguez, T. Quintanar, Gimenez, D. Malon, Garcia, A.I. Ballesteros, Bañón, D., Lopez-Tarruella Cobo, S., Jimenez, M. Martin
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
73P Effect of diarrheal prophylaxis or dose escalation on neratinib-associated diarrhea and tolerability in patients with HER2+ early-stage breast cancer: Final findings from the CONTROL trial
Chan, A., Ruiz Borrego, M., Marx, G., Brufsky, A., Chien, A.J., Thirlwell, M.P., Trudeau, M.E., Bose, R., García Saenz, J.Á., Egle, D., Pistilli, B., Wassermann, J., Cheong, K.A., Semsek, D., Singer, C.F., Diprimeo, D., Foruzan, N., McCulloch, L.M., Barcenas, C.H.
Published in Annals of oncology (01.05.2022)
Published in Annals of oncology (01.05.2022)
Get full text
Journal Article
141MO Pathological response and early survival data according to TNBCtype4 classifier in operable triple-negative breast cancer (TNBC) treated with neoadjuvant carboplatin and docetaxel
Echavarria Diaz-Guardamino, I., Lopez-Tarruella Cobo, S., Del Monte-Millan, M., Alvarez, E., Jerez, Y., Moreno Anton, F., García Saenz, J.Á., Massarrah, T., Ocaña, I., Cebollero, M., Ballesteros Garcia, A.I., Bohn Sarmiento, U., Gomez, H., Fuentes, H.A., Herrero Lopez, B., Gamez Casado, S., Bueno, O., Jiménez-Santos, M.J., Roche-Molina, M., Martin Jimenez, M.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
262P Niraparib plus aromatase inhibitors (AI) for germinal mutated BRCA1/2 (gBRCAm) or homologous recombination-deficient (HRd), hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer (ABC): LUZERN interim analysis
Pimentel, I., Lema Roso, L., Ramos Vazquez, M., García Saenz, J.Á., Palacios-Ozores, P., De la Haba Rodriguez, J., Blanch, S., Prat, A., Ales Martínez, J.E., Alba Conejo, E., Balmaña, J., Perez Garcia, J.M., Sampayo-Cordero, M., Malfettone, A., Cortés, J., Llombart Cussac, A.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
85P Correlation between nCOUNTER PAM-50 assay and three IHC-based surrogate intrinsic breast cancer subtype classifiers: A real-world study
Martín, M., Del Monte-Millán, M., Jerez, Y., Echavarria Diaz-Guardamino, I., Herrero Lopez, B., Gamez Casado, S., Roche-Molina, M., Marquez-Rodas, I., Cebollero, M., Alvarez, E., Massarrah, T., Ocaña, I., Arias, A., García Saenz, J.Á., Moreno Anton, F., Olier Garate, C., Moreno Muñoz, D., Marrupe Gonzalez, D., Merina, T., Lopez-Tarruella Cobo, S.
Published in Annals of oncology (01.05.2022)
Published in Annals of oncology (01.05.2022)
Get full text
Journal Article
TNBC-DX genomic test in early-stage triple-negative breast cancer treated with neoadjuvant taxane-based therapy
Martín, M., Stecklein, S.R., Gluz, O., Villacampa, G., Monte-Millán, M., Nitz, U., Cobo, S., Christgen, M., Brasó-Maristany, F., Álvarez, E.L., Echavarría, I., Conte, B., Kuemmel, S., Bueno-Muiño, C., Jerez, Y., Kates, R., Cebollero, M., Kolberg-Liedtke, C., Bueno, O., García-Saenz, J.Á., Moreno, F., Grischke, E.-M., Forstbauer, H., Braun, M., Warm, M., Hackmann, J., Uleer, C., Aktas, B., Schumacher, C., Wuerstleins, R., Graeser, M., zu Eulenburg, C., Kreipe, H.H., Gómez, H., Massarrah, T., Herrero, B., Paré, L., Bohn, U., López-Tarruella, S., Vivancos, A., Sanfeliu, E., Parker, J.S., Perou, C.M., Villagrasa, P., Prat, A., Sharma, P., Harbeck, N.
Published in Annals of oncology (16.10.2024)
Published in Annals of oncology (16.10.2024)
Get full text
Journal Article
260P LUZERN: Phase II trial of niraparib and aromatase inhibitors (AI) for pretreated hormone receptor-positive/HER2-negative germline BRCA-mutated advanced breast cancer
Blanch, S., Balmaña, J., Roso, L. Lema, Saenz, J.Á. García, Vegas, E. Filipovich, Jiménez-Rodríguez, B., De la Haba Rodriguez, J., García, J.M. Pérez, Campolier, M., Shimizu, E., Alcalá-López, D., Cordero, M. Sampayo, Castan, J. Cortes, Cussac, A. Llombart
Published in ESMO open (01.05.2024)
Published in ESMO open (01.05.2024)
Get full text
Journal Article
216P Relationship between regulatory T lymphocytes (Treg): Related genes and pathological response to neoadjuvant docetaxel-carboplatin in early-stage triple-negative breast cancer (TNBC)
Martín Lozano, R., Roche-Molina, M., Alvarez, E., Del Monte-Millan, M., Jerez Gilarranz, Y., Moreno Anton, F., García Saenz, J.Á., Echavarria Diaz-Guardamino, I., Massarrah, T., Cebollero, M., Ballesteros Garcia, A.I., Bohn Sarmiento, U., Gomez Moreno, H.L., Fuentes, H.A., Herrero Lopez, B., Gamez Casado, S., Bueno Muiño, C., Bueno, O., Lopez-Tarruella Cobo, S., Martin Jimenez, M.
Published in Immuno-oncology technology (01.12.2022)
Published in Immuno-oncology technology (01.12.2022)
Get full text
Journal Article
P198 Prospective trans-GEICAM study of the impact of the 21-gene recurrence score assay and traditional clinico-pathological factors on clinical decision making in women with estrogen receptor-positive, HER2-negative, node-negative breast cancer
Albanell, J, Colomer, R, Ruiz-Borrego, M, Alba, E, García Saenz, J.A, Martin, M, Tusquets, I, Rojo, F, Faull, I, Lluch, A
Published in Breast (Edinburgh) (2011)
Published in Breast (Edinburgh) (2011)
Get full text
Journal Article
Phase I/II Study of Concurrent Erlotinib and Chemoradiation for Post-Resected Locally Advanced Squamous Head and Neck Cancer (HNSCC): A Gicor Study
Arias de la Vega, F, Herruzo, I, de las Heras, M, de la Torre, A, del Río, L, Contreras, J, Prieto, I, García Saenz, J.A, Amador, M.L, Calvo, F.A
Published in International journal of radiation oncology, biology, physics (01.11.2007)
Published in International journal of radiation oncology, biology, physics (01.11.2007)
Get full text
Journal Article
Evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for hormone receptor–positive metastatic breast cancer: a pooled analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trials
Martín, M., Loibl, S., Hyslop, T., De la Haba-Rodríguez, J., Aktas, B., Cirrincione, C.T., Mehta, K., Barry, W.T., Morales, S., Carey, L.A., Garcia-Saenz, J.A., Partridge, A., Martinez-Jañez, N., Hahn, O., Winer, E., Guerrero-Zotano, A., Hudis, C., Casas, M., Rodriguez-Martin, C., Furlanetto, J., Carrasco, E., Dickler, M.N.
Published in European journal of cancer (1990) (01.08.2019)
Published in European journal of cancer (1990) (01.08.2019)
Get full text
Journal Article
Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial
Jhaveri, K., Eli, L.D., Wildiers, H., Hurvitz, S.A., Guerrero-Zotano, A., Unni, N., Brufsky, A., Park, H., Waisman, J., Yang, E.S., Spanggaard, I., Reid, S., Burkard, M.E., Vinayak, S., Prat, A., Arnedos, M., Bidard, F.-C., Loi, S., Crown, J., Bhave, M., Piha-Paul, S.A., Suga, J.M., Chia, S., Saura, C., Garcia-Saenz, J.Á., Gambardella, V., de Miguel, M.J., Gal-Yam, E.N., Rapael, A., Stemmer, S.M., Ma, C., Hanker, A.B., Ye, D., Goldman, J.W., Bose, R., Peterson, L., Bell, J.S.K., Frazier, A., DiPrimeo, D., Wong, A., Arteaga, C.L., Solit, D.B.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
182TiP Effectiveness of niraparib plus aromatase inhibitors (AI) for germinal BRCA1/2-mutated (gBRCAm) or homologous recombination deficient (HRD), hormone receptor (HR)+/human epidermal growth factor receptor 2 (HER2)- advanced breast cancer (ABC). The LUZERN Strategy
Blanch, S., Pérez-García, J.M., Balmaña, J., Prat, A., Alés-Martínez, J.E., de la Haba, J., Alba, E., Palacios-Ozores, P., Ramos, M., Lema, L., García Sáenz, J.Á., Sampayo-Cordero, M., Malfettone, A., Cortés, J., Llombart Cussac, A.
Published in Annals of oncology (01.05.2020)
Published in Annals of oncology (01.05.2020)
Get full text
Journal Article